Across TCGA pan-cancer cohorts, EIF2AP4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of EIF2AP4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where EIF2AP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EIF2AP4 is over-expressed in tumor.

KIRC and LUAD are the cancer types where EIF2AP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EIF2AP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	III,IV	+0.032	.035	4	view →
LUAD	Male	All	+0.023	.018	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: EIF2AP4 RNA expression & survival · all EIF2AP4 data types